Loading...
Ategrity Specialty Insurance Company Holdings (ASIC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance and premium growth, the recent price downgrade by Citi, combined with a 4.63% drop in regular market trading, suggests a more balanced risk/reward scenario. The absence of strong proprietary trading signals and neutral sentiment from hedge funds and insiders further supports a cautious approach.
The MACD is positive but contracting, RSI is neutral at 67.606, and moving averages are converging, suggesting no clear trend. The stock is trading near its R1 resistance level of 22.94, with support at 17.496, indicating limited upside potential in the short term.
Q4 non-GAAP EPS of $0.51 and revenue of $123.34 million exceeded expectations. Analysts like JPMorgan and Barclays raised their price targets recently, citing strong growth and a differentiated business model.
Citi downgraded the stock to Neutral from Buy, citing valuation concerns after a 36% price increase since the Q4 report. The stock dropped 4.63% in regular market trading, and hedge funds and insiders show no significant trading activity.
In Q4 2025, the company reported a 30% YoY increase in gross written premiums and adjusted net income of $25.4 million. For Q3 2025, revenue grew by 30.82% YoY, net income increased by 76.20% YoY, and EPS rose by 25% YoY, showcasing robust growth trends.
Mixed sentiment. Citi downgraded the stock to Neutral with a $27 price target due to valuation concerns. JPMorgan and Barclays raised their price targets to $27 and $26, respectively, citing strong growth and differentiation in the specialty insurance market.